Skip to main content
. 2016 Mar 15;35(1):17–23. doi: 10.1136/acupmed-2015-010854

Table 3.

Primary outcome measure (IBS SSS scores) between baseline and 24-month follow-up, and between-group differences (n=233)

IBS SSS Baseline mean (95% CI) Month 3 mean (95% CI) Month 6 mean (95% CI) Month 9 mean (95% CI) Month 12 mean (95% CI) Month 24 mean (95% CI)
Acupuncture group (n=116) 278.45 (268.54 to 288.35) 213.71 (198.17 to 229.24) 202.99 (186.97 to 219.01) 211.86 (194.97 to 228.76) 210.89 (194.70 to 227.08) 215.62 (198.60 to 232.64)
Usual care group (n=117) 240.98 (224.89 to 257.07) 226.68 (210.20 to 243.16) 235.96 (218.91 to 253.01) 233.95 (217.24 to 250.65) 233.90 (215.48 to 252.31)
Between-group differences in means (acupuncture vs. usual care) −27.27 (−47.69 to −6.86)* −23.69 (−45.17 to −2.21)* −24.09 (−45.59 to −2.59)* −23.06 (−44.52 to −1.59)* −18.28 (−40.95 to 4.40)

Data are predicted means and 95% CIs from the unstructured multivariate linear model. At baseline there is only one predicted mean since the corresponding outcome does not depend on treatment.

*p<0.05.

IBS SSS, irritable bowel syndrome symptom severity score.